DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 141-146

  Veras, Katherine ^a   Almeida, Felipe Natali ^a   Nachbar, Renato Tadeu ^a   de Jesus, Daniel Simões ^a   Camporez, João Paulo ^a   Carpinelli, Ângelo Rafael ^a   Goedecke, Julia H ^b   de Oliveira Carvalho, Carla Roberta ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

High fat diet; Insulin secretion; Insulin sensitivity; Menopause; P Akt Akt; Pancreatic islets

Indexed keywords

ESTROGEN; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE; PROTEIN KINASE B; SERINE; TESTOSTERONE; ESTRADIOL; PRASTERONE SULFATE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA FRAGMENTATION; DRUG IMPLANTATION; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OBESITY; OVARIECTOMY; PANCREAS FUNCTION; PANCREAS ISLET; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TESTOSTERONE BLOOD LEVEL; UTERUS WEIGHT; ANIMAL MODEL; COMPARATIVE STUDY; DIABETES MELLITUS; HYPERTENSION; IMMUNOBLOTTING; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; OSTEOPOROSIS; POSTMENOPAUSE; PROTEIN EXPRESSION; SUPPLEMENTATION;

RATTUS;

EID: 84893423307     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.01.005     Document Type: Article

References (42)

1. Tchernof A., Calles-Escandon J., Sites C.K., Poehlman E.T. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron. Artery Dis. 1998, 9:503-511.
2. Polotsky H.N., Polotsky A.J. Metabolic implications of menopause. Semin. Reprod. Med. 2010, 28:426-434.
3. Brown L.M., Gent L., Davis K., Clegg D.J. Metabolic impact of sex hormones on obesity. Brain Res. 2010, 1350:77-85.
4. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., Kaplitt M.G., Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2501-2506.
5. Livingstone C., Collison M. Sex steroids and insulin resistance. Clin. Sci. (Lond) 2002, 102:151-166.
6. Liu S., Mauvais-Jarvis F. Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology 2010, 151:859-864.
7. El Seifi S., Green I.C., Perrin D. Insulin release and steroid-hormone binding in isolated islets of langerhans in the rat: effects of ovariectomy. J. Endocrinol. 1981, 90:59-67.
8. Choi S.B., Jang J.S., Park S. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 2005, 146:4786-4794.
9. Le May C., Chu K., Hu M., Ortega C.S., Simpson E.R., Korach K.S., Tsai M.J., Mauvais-Jarvis F. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9232-9237.
10. Tiano J.P., Mauvais-Jarvis F. Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat. Rev. Endocrinol. 2012, 8:342-351.
11. Nadal A., Alonso-Magdalena P., Soriano S., Ripoll C., Fuentes E., Quesada I., Ropero A.B. Role of estrogen receptors alpha, beta and GPER1/GPR30 in pancreatic beta-cells. Front. Biosci. 2011, 16:251-260.
12. Ropero A.B., Pang Y., Alonso-Magdalena P., Thomas P., Nadal A. Role of ERβ and GPR30 in the endocrine pancreas: a matter of estrogen dose. Steroids 2012, 77:951-958.
13. Mauvais-Jarvis F., Clegg D.J., Hevener A.L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 2013, 34:309-338.
14. Rhodes C.J., White M.F., Leahy J.L., Kahn S.E. Direct autocrine action of insulin on β-cells: does it make physiological sense?. Diabetes 2013, 62:2157-2163.
15. Goldfine A.B., Kulkarni R.N. Modulation of β-cell function: a translational journey from the bench to the bedside. Diabetes Obes. Metab. 2012, 14(Suppl. 3):152-160.
16. Xuan S., et al. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J. Clin. Invest. 2002, 110:1011-1019.
17. Kulkarni R.N., Brüning J.C., Winnay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
18. Elghazi L., Balcazar N., Bernal-Mizrachi E. Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function. Int. J. Biochem. Cell Biol. 2006, 38:157-163.
19. Vermeulen A. Dehydroepiandrosterone sulfate and aging. Ann. N.Y. Acad. Sci. 1995, 774:121-127.
20. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann. Endocrinol. (Paris) 2003, 64:95-107.
21. Cameron D.R., Braunstein G.D. The use of dehydroepiandrosterone therapy in clinical practice. Treat. Endocrinol. 2005, 4:95-114.
22. Camporez J.P., Akamine E.H., Davel A.P., Franci C.R., Rossoni L.V., Carvalho C.R. Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats. J. Physiol. 2011, 589:2585-2596.
23. Coleman D.L., Leiter E.H., Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982, 31:830-833.
24. Perzyło K., Kulik-Rechberger B., Gałczyński K., Rechberger T. Intracrinology and dehydroepiandrosterone - a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women. Ginekol. Pol. 2011, 82:690-695.
25. Gómez-Santos C., Larqué E., Granero E., Hernández-Morante J.J., Garaulet M. Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profile in plasma of obese women. Steroids 2011, 76:1425-1432.
26. Yen T.T., Allan J.A., Pearson D.V., Acton J.M., Greenberg M.M. Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids 1977, 12:409-413.
27. Medina M.C., et al. Dehydroepiandrosterone increases beta-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Lett. 2006, 580:285-290.
28. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
29. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
30. Scott A.M., Atwater I., Rojas E. A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia 1981, 21:470-475.
31. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
32. Azevedo-Martins A.K., Monteiro A.P., Lima C.L., Lenzen S., Curi R. Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells. Toxicol. In Vitro 2006, 20:1106-1113.
33. Barrett-Connor E., Khaw K.T., Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med. 1986, 315:1519-1524.
34. Lea-Currie Y.R., Wen P., McIntosh M.K. Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 1997, 21:1058-1064.
35. Campbell C.S., Caperuto L.C., Hirata A.E., Araujo E.P., Velloso L.A., Saad M.J., Carvalho C.R. The phosphatidylinositol/AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sci. 2004, 76:57-70.
36. Dillon J.S., et al. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 2000, 49:2012-2020.
37. Hong J., Stubbins R.E., Smith R.R., Harvey A.E., Núñez N.P. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr. J. 2009, 8:11.
38. Sato K., Iemitsu M., Aizawa K., Ajisaka R. DHEA improves impaired activation of Akt and PKC zeta/lambda-GLUT4 pathway in skeletal muscle and improves hyperglycaemia in streptozotocin-induced diabetes rats. Acta Physiol. (Oxf.) 2009, 197:217-225.
39. Dickson L.M., Rhodes C.J. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E192-E198.
40. Bernal-Mizrachi E., Fatrai S., Johnson J.D., Ohsugi M., Otani K., Han Z., Polonsky K.S., Permutt M.A. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J. Clin. Invest. 2004, 114:928-936.
41. Aoyagi K., Ohara-Imaizumi M., Nishiwaki C., Nakamichi Y., Ueki K., Kadowaki T., Nagamatsu S. Acute inhibition of PI3K-PDK1-Akt pathway potentiates insulin secretion through upregulation of newcomer granule fusions in pancreatic β-cells. PLoS One 2012, 7:e47381.
42. Kaneko K., et al. Class IA phosphatidylinositol 3-kinase in pancreatic β cells controls insulin secretion by multiple mechanisms. Cell Metab. 2010, 12:619-632.